Perceptions, attitudes and beliefs among allied healthcare professionals managing people with Type 2 diabetes: an international cross-sectional survey

References

• International Diabetes Federation. IDF Diabetes atlas seventh edition; 2015. [cited 2017 Sep 1]. Available from http://www.diabetesatlas.org/.
   Google Scholar
• Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–22. doi: 10.1038/nrendo.2016.105
   PubMed Web of Science ®Google Scholar
• Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–200. doi: 10.7150/ijms.10001
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79. doi: 10.2337/dc12-0413
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. doi: 10.1016/S0140-6736(98)07019-6
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89. doi: 10.1056/NEJMoa0806470
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Aschner P, Del Prato S, LaSalle J, Ji L, Matthaei S. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes. Diab Vasc Dis Res. 2013;10(5):397–409. doi: 10.1177/1479164113490765
   PubMed Web of Science ®Google Scholar
• Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32(5):442–58. doi: 10.1002/dmrr.2827
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2013;37(Suppl. 1):S1–S212.
   PubMedGoogle Scholar
• Del Prato S, Felton AM, Munro N, Nesto R, Zimmet P, Zinman B. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract. 2005;59(11):1345–55. doi: 10.1111/j.1742-1241.2005.00674.x
   PubMed Web of Science ®Google Scholar
• Del Prato S, LaSalle J, Matthaei S, Bailey CJ. Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int J Clin Pract. 2010;64(3):295–304. doi: 10.1111/j.1742-1241.2009.02227.x
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Del Prato S, Eddy D, Zinman B. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract. 2005;59(11):1309–16. doi: 10.1111/j.1742-1241.2005.00675.x
   PubMed Web of Science ®Google Scholar
• Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol. 2010;47(2):137–45. doi: 10.1007/s00592-009-0138-z
   PubMed Web of Science ®Google Scholar
• Felton AM, LaSalle J, McGill M. Treatment urgency: the importance of getting people with type 2 diabetes to target promptly. Diabetes Res Clin Pract. 2016;117:100–3. doi: 10.1016/j.diabres.2016.04.026
   PubMed Web of Science ®Google Scholar
• Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Vokó Z, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105(3):302–12. doi: 10.1016/j.diabres.2014.05.005
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673–79. doi: 10.2337/diacare.28.11.2673
   PubMed Web of Science ®Google Scholar
• Holt RI, Nicolucci A, Kovacs Burns K, Escalante M, Forbes A, Hermanns N, et al. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care-healthcare professional perspective. Diabet Med. 2013;30(7):789–98. doi: 10.1111/dme.12242
   PubMed Web of Science ®Google Scholar
• Peytremann-Bridevaux I, Lauvergeon S, Mettler D, Burnand B. Diabetes care: opinions, needs and proposed solutions of Swiss patients and healthcare professionals: a qualitative study. Diabetes Res Clin Pract. 2012;97(2):242–50. doi: 10.1016/j.diabres.2012.02.021
   PubMed Web of Science ®Google Scholar